Antibody Type: Recombinant Mouse Monoclonal

Application: ELISA, IHC, IF, FCM

Reactivity: Human

mIgG2a

1Q367

Human

1. IHC image of TMAH-00045 diluted at 1:50 and staining in paraffin-embedded human endometrial cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-Mouse IgG labeled by HRP and visualized using 0.05% DAB.
2. Immunofluorescence staining of Hela cell with TMAH-00045 at 1:10, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was FITC-conjugated AffiniPure Goat Anti-Mouse IgG(H+L).
3. Immunofluorescence staining of MCF7 cell with TMAH-00045 at 1:10, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was FITC-conjugated AffiniPure Goat Anti-Mouse IgG(H+L).
4. Overlay Peak curve showing Hela cells stained with TMAH-00045 (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-Mouse IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was mouse IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.

ELISA, IHC, IF, FCM

IHC:1:50-1:200; IF:1:50-1:200; FCM:1:50-1:200.

Monoclonal

Unconjugated

Recombinant Protein: Human AIFM1 Protein

Human

9131

Epigenetics and Nuclear Signaling, Cancer, Cell biology, Metabolism